Carregant...
Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis
The main protease (M(pro)) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an important therapeutic target as it plays a major role in the processing and maturation of the viral polyprotein. GC376 is a pre-clinical dipeptide-based protease inhibitor that has been previously used f...
Guardat en:
| Publicat a: | Ann Med Surg (Lond) |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7797473/ https://ncbi.nlm.nih.gov/pubmed/33456770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amsu.2020.12.030 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|